FREE Daily Stock Alerts From Stock-PR.com
Entergy Corporation (NYSE:ETR) announced it is working with Coulomb Technologies to fund and donate 16 electric vehicle charging stations at college campuses in and around Entergy's four-state service area. The first two Entergy-funded charging stations were unveiled during a special event at Louisiana State University as Entergy and LSU launched one of the state's first major forays into the electric vehicle market. The event featured Dr. Michael Martin, LSU Chancellor; Bill Mohl, president and chief executive officer, Entergy Louisiana, LLC and Entergy Gulf States Louisiana, L.L.C.; and Allan G. Pulsipher, executive director, LSU Center for Energy Studies.
Entergy Corporation is an integrated energy company engaged primarily in electric power production and retail distribution operations. Entergy owns and operates power plants with approximately 30,000 megawatts of electric generating capacity, and it is the second-largest nuclear generator in the United States. Entergy's online address is www.entergy.com.
Power3 Medical Products, Inc. (OTC:PWRM)
The NuroPro Blood Test is Power3's medical diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer's disease, ALS (Lou Gehrig's disease), and Parkinson's disease. Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.
Some symptoms of Amyotrophic lateral sclerosis (ALS) are:
" twitching, cramping, or stiffness of muscles;
" muscle weakness affecting an arm or a leg;
" slurred and nasal speech;
" Difficulty chewing or swallowing.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease).Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroProÂ®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
Please visit Power3 Medical Products, Inc website http://www.power3medical.com.
Vishay Precision Group, Inc. (NYSE:VPG) announced that its Vishay Foil Resistors division's Design and Selector Guide for High-Precision Resistors is now available as a free download at www.vishaypg.com/doc?49789. The 92-page brochure serves as a comprehensive resource that helps designers understand the importance of resistors and select the best device to meet the needs of their high-precision applications.
Vishay Precision Group (VPG) produces sensors based on precision resistive foil technology, and sensor-based systems. It provides vertically integrated products and solutions for multiple growing markets in the areas of stress, force, weight, pressure and current measurements. Vishay Precision Group may be found on the Internet at www.vishaypg.com
Baker Hughes Incorporated (NYSE:BHI) announced that Adam B. Anderson will be appointed Baker Hughes' vice president, investor relations became effective July 1, 2011. In this position, he will be located in Houston and will report to Peter A. Ragauss, senior vice president and chief financial officer. Adam will succeed Gary R. Flaharty, who will assume a senior role in Baker Hughes' supply chain organization effective August 1, 2011.
Baker Hughes Incorporated supplies wellbore related products, and technology services and systems for drilling, formation evaluation, completion and production, and reservoir technology and consulting to the oil and natural gas industry worldwide.
First Commonwealth Financial Corporation (NYSE:FCF) announced that it will host a conference call on Thursday, July 28, 2011 at 2:00 p.m. local time to discuss financial results for the quarter ended June 30, 2011. The call will be hosted by John J. Dolan, President and Chief Executive Officer. He will be joined by Robert E. Rout, Executive Vice President and Chief Financial Officer and T. Michael Price, President of First Commonwealth Bank. First Commonwealth will issue a results reporting its second quarter 2011 financial results by 9:00 a.m. on July 27, 2011.
First Commonwealth Financial Corporation operates as the holding company for First Commonwealth Bank that provides consumer and commercial banking services to individuals and small and mid-sized businesses in central and western Pennsylvania.
Airgas, Inc. (NYSE:ARG) will release its fiscal 2012 first quarter earnings before the market opens on Thursday, July 28, 2011, and will host a teleconference at 10:00 a.m. ET that same day. The presentation materials will also be available before the market opens on July 28 on the Internet at http://investor.shareholder.com/arg/slides.cfm. A webcast of the teleconference will be available live and on demand through August 26 at http://investor.shareholder.com/arg/events.cfm.
Airgas, Inc., through its subsidiaries, is the largest U.S. distributor of industrial, medical, and specialty gases, and hardgoods, such as welding equipment and supplies. For more information, please visit www.airgas.com.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).
Sign Up For Free Stock Alerts At http://stock-pr.com/signup